Who owns TRAVERE THERAPEUTICS INC (TVTX?
- CUSIP Number: 89422gaa5
Tip: Access positions for across all investors
Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Travere Therapeutics stock
Who bought or sold TRAVERE THERAPEUTICS INC (TVTX this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wolverine Asset Management | 45M | $29M | 0% | Sep 2023 |
|
| D. E. Shaw & Co | 41M | $26M | 0% | Sep 2023 |
|
| Braidwell | 28M | $18M | 0% | Sep 2023 |
|
| Highbridge Capital Management | 27M | $17M | 279% | Sep 2023 |
|
| UBS O'Connor | 25M | $16M | 0% | Sep 2023 |
|
| Lazard Asset Management | 24M | $16M | -13% | Sep 2023 |
|
| Capstone Investment Advisors | 23M | $15M | -47% | Sep 2023 |
|
| Aviva | 23M | $15M | 28% | Sep 2023 |
|
| Citigroup | 20M | $13M | 33% | Sep 2023 |
|
| Silverback Asset Management | 13M | $8.1B | 100% | Sep 2023 |
|
| Segantii Capital Management | 7.5M | $4.9M | -6% | Sep 2023 |
|
| Morgan Stanley | 3.1M | $2.0M | 93% | Sep 2023 |
|
| Readystate Asset Management | 3.0M | $1.9M | -67% | Sep 2023 |
|
| Jane Street | 2.7M | $1.8M | -13% | Sep 2023 |
|
| Point72 Asset Management | 2.6M | $1.7M | -70% | Sep 2023 |
|
| BlackRock | 2.2M | $1.4M | 22% | Sep 2023 |
|
| Linden Advisors | 1.5M | $963M | -89% | Sep 2023 |
|
| Lion Point Capital | 1.0M | $648k | 100% | Sep 2023 |
|
| Leucadia National Corporation | 500k | $323k | 100% | Sep 2023 |
|
| Caas Capital Management | 500k | $317k | 0% | Sep 2023 |
|
| Nomura Holdings | 480k | $4.3M | -18% | Sep 2023 |
|
| Jpmorgan Chase & Co | 125k | $81k | 0% | Sep 2023 |
|
| Context Capital Management | 41k | $27M | 41% | Sep 2023 |
|
Who sold out of Travere Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Centiva Capital | Jun 2023 | 2.5M | $2.0M |
| Laurion Capital Management | Jun 2023 | 1.5M | $1.2M |